Restorative Botanicals Awarded USDA Organic Certification for CBD-Rich Hemp Oil Products
BOULDER, Colo. – Restorative Botanicals, company in the cannabinoid-rich hemp product category, is pleased to announced that it has added the USDA Organic certification to its long list of independent, third-party certifications that include cGMP (Current Good Manufacturing Practices for supplements), US Hemp Authority, Kosher, and Leaping Bunny cruelty-free certifications.
“What makes Restorative Botanicals stand out in the cannabinoid-rich hemp product category is our dedication to a simple guiding principle: We only make and sell the highest quality products that we are confident in sharing with our own family, friends, and pets,” states Bernard Perry, Founder & President of Restorative Botanicals. “The USDA Organic certification is an extension of our commitment to deliver premium, hemp-derived CBD products that our customers and retail partners can trust.”
Restorative Botanicals thoughtfully formulates their innovative hemp extract blends with other all-natural and highly effective ingredients to produce uniquely functional products. The result is a line of CBD supplements that help balance the body’s interconnected systems, providing significant health and wellness benefits.
“We’re product innovators who want everyone to experience what high quality, safe and effective CBD products can do for them,” said Meagan Thomas, Restorative Botanicals Director of Business Development. “This is why we offer our broad line of products through independent and regional retailers, white label partner programs, and direct to consumers online. Restorative Botanicals is raising the bar for what consumers deserve from the hemp industry.”
(This information is primarily sourced from Restorative Botanicals. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Latest News
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...